Skip to contentFOLETTA MARK G — AMYLIN PHARMACEUTICALS INC insider: 402 transactions · InsiderLensFOLETTA MARK G
- Director at ANADYS PHARMACEUTICALS INC · on record since Jun 2, 2006
- Director at AMERON INTERNATIONAL CORP · on record since May 4, 2026
- Director at AMN HEALTHCARE SERVICES INC · on record since Dec 12, 2012
- Director at DEXCOM INC · on record since May 11, 2026
- Director at Regulus Therapeutics Inc. · on record since Jan 31, 2013
- Director at AMBIT BIOSCIENCES CORP · on record since Jan 27, 2014
- Interim CFO at BIO IMAGING TECHNOLOGIES INC · on record since Aug 20, 2015
- VP Finance & CFO at AMYLIN PHARMACEUTICALS INC · on record since Nov 1, 2004
- EVP & Chief Financial Officer at Forte Biosciences, Inc. · on record since May 31, 2017
- Director at ENANTA PHARMACEUTICALS INC · on record since Jul 1, 2020
Insider trading activity of FOLETTA MARK G
- Transactions on record
- 402
- since May 6, 2004
- Open-market buys
- 4
- $176.4K
- Open-market sells
- 140
- $8.9M
- Companies traded
- 10
- last filing Jun 17, 2026
Figures computed from official regulatory filings — methodology.
Companies where FOLETTA MARK G has traded
- DEXCOM INC125 tx · $5.3M · Jun 17, 2026
- AMERON INTERNATIONAL CORP38 tx · $1.1M · Jun 17, 2026
- ENANTA PHARMACEUTICALS INC7 tx · Mar 13, 2026
- Forte Biosciences, Inc.7 tx · $92.8K · Oct 4, 2019
- Regulus Therapeutics Inc.8 tx · $140.4K · Dec 6, 2017
- AMN HEALTHCARE SERVICES INC7 tx · Apr 22, 2016
- BIO IMAGING TECHNOLOGIES INC1 tx · Sep 2, 2015
- AMBIT BIOSCIENCES CORP4 tx · $124.1K · Nov 12, 2014
- AMYLIN PHARMACEUTICALS INC197 tx · $26.4M · Aug 10, 2012
Track record of FOLETTA MARK G
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of FOLETTA MARK G
Co-insiders of FOLETTA MARK G
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
8 tx · May 27, 2011
Jackson Denise LAMERON INTERNATIONAL CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 17, 2026 | Sell | -3,801 | 74.10 USD | — | SEC |
| Jun 17, 2026 | Sell | -1,681 | 31.07 USD | — | SEC |
| Jun 17, 2026 | Sell | -199 | 74.82 USD | — | SEC |
| Jun 17, 2026 | Sell | -2,000 | 31.07 USD | — | SEC |
| Jun 1, 2026 | Award | 6,331 | 0.00 USD | $0 | SEC |
| May 11, 2026 | Gift | -5,731 | 0.00 USD | $0 | SEC |
| May 11, 2026 | Gift | 5,731 | 0.00 USD | $0 | SEC |
| May 4, 2026 | ExerciseD | -8,325 | 0.00 USD | $0 | SEC |
| May 4, 2026 | Exercise | 8,325 | 0.00 USD | $0 | SEC |
| May 4, 2026 | AwardD | 8,304 | 0.00 USD | $0 | SEC |
| Mar 13, 2026 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Aug 18, 2025 | Sell | -195 | 81.54 USD | $15.9K | SEC |
| Aug 18, 2025 | Sell | -2,555 | 81.02 USD | $207K | SEC |
| Jul 17, 2025 | Sell | -8 | 86.03 USD | $688.2 | SEC |
| Jul 17, 2025 | Sell | -2,742 | 85.17 USD | $233.5K | SEC |
| Jun 18, 2025 | Sell | -2,750 | 83.13 USD | $228.6K | SEC |
| May 12, 2025 | Gift | -2,973 | 0.00 USD | $0 | SEC |
| May 12, 2025 | Gift | 2,973 | 0.00 USD | $0 | SEC |
| May 12, 2025 | Award | 5,731 | 0.00 USD | $0 | SEC |
| May 6, 2025 | AwardD | 8,325 | 0.00 USD | $0 | SEC |
| Apr 21, 2025 | ExerciseD | -3,019 | 0.00 USD | $0 | SEC |
| Apr 21, 2025 | Exercise | 3,019 | 0.00 USD | $0 | SEC |
| Mar 14, 2025 | AwardD | 15,700 | 0.00 USD | $0 | SEC |
| Jun 20, 2024 | Sell | -475 | 117.77 USD | $55.9K | SEC |
| Jun 20, 2024 | Sell | -299 | 117.25 USD | $35.1K | SEC |